0.2% dry yeast (Mitsubishi Tanabe Pharma, Osaka, Japan), 0.4% CaCO 3 (Kozakai Pharmaceutical, Tokyo, Japan) and 1% Diaion HP-20 (Mitsubishi Chemical, Tokyo, Japan), pH 7.0 (before sterilization). The mycelia from the culture broth (100 mlÂ20 flasks) were treated with Me 2 CO (400 ml). After in vacuo concentration, the residue was extracted with EtOAc. The organic layer was dried over anhydrous Na 2 SO 4 and evaporated to dryness in vacuo. The residue (312 mg) was purified using normal-phase medium-pressure liquid chromatography (Purif-Pack, SI 30 mm; Shoko Scientific, Yokohama, Japan) and developed with hexane-EtOAc (1:1). The active fraction was further purified by preparative reversed-phase HPLC using a CAPCELL PAK C 18 MG II column (5.0 mm, 20 i.d. Â150 mm; Shiseido, Tokyo, Japan) and developed with 85% MeOH-H 2 O containing 0.4% formic acid (flow rate, 10 ml min À1 ) to yield 1 (20.0 mg, retention time¼32.5 min). Table 1 . Analysis of double-quantum filtered (DQF)-COSY and constant time heteronuclear multiple bond correlation 4 spectra revealed the structure of 1 as follows.
In the DQF-COSY spectrum, we observed four allylic couplings between a methyl proton 2-CH 3 The four olefins at C-2, C-4, C-12 and C-2¢ were all determined to be E-configuration on the basis of their high-field 13 C chemical shifts of the methyl residues 2-CH 3 (d C 13.7) and 4-CH 3 (d C 15.2), and the coupling constants between 12-H/13-H (J 12-H-13-H ,-15.0 Hz) and 2¢-H/3¢-H (J 2¢-H-3¢-H ,-15.5 Hz). Another olefin at C-10 also appeared to possess the E-configuration when the 13 C chemical shifts at 10-CH 3 (d C 20.1) were compared with those of known analogues. 5 Thus, the structure of 1 was determined to be that of a new 16-membered macrolide, as shown in Figure 1a . The structure of 1 was found to be structurally related to bafilomycin C 1 , which shows V-ATPase inhibitory activity, and differs from that of bafilomycin C 1 in the presence of the methyl group at the C-2 position.
The cytotoxic activity of 1 against human cervical carcinoma 2 Dye accumulation (orange dots) was found to be inhibited by the administration of 1 (100 nM) (Figure 2 ), indicating the inhibitory property of 1 against V-ATPase.
DMSO JBIR-100 x400 Figure 2 Inhibition of V-ATPase activity by 1 in HeLa cells. Cells were treated with 100 nM of 1 for an hour. Then, the cells were stained with acridine orange (Sigma, St Louis, MO, USA) at a concentration of 0.5 mg ml À1 , incubated for 10 min, and washed twice with phosphatebuffered saline. The images were visualized under an LSM 510 Confocal Laser Scanning microscope (Carl Zeiss MicroImaging, Thornwood, NY, USA). Acridine orange emits red fluorescence in acidic vesicular organelles and green fluorescence in the cytoplasm and nucleus.
